Next Article in Journal
Endogenous Fluorescent Proteins in the Mucus of an Intertidal Polychaeta: Clues for Biotechnology
Previous Article in Journal
Fucoxanthin from Algae to Human, an Extraordinary Bioresource: Insights and Advances in up and Downstream Processes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 20
Issue 4
10.3390/md20040223
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Purification, Chemical Characterization and Immunomodulatory Activity of a Sulfated Polysaccharide from Marine Brown Algae Durvillaea antarctica

by
Ling Qin
1,
Hui Xu
1,
Yingying He
1,
Chen Liang
1,
Kai Wang
1,
Junhan Cao
1,
Changfeng Qu
1,2,3,* and
Jinlai Miao
1,2,3,*
1
Key Laboratory of Marine Eco-Environmental Science and Technology, First Institute of Oceanography, Ministry of Natural Resource, Qingdao 266061, China
2
Laboratory for Marine Drugs and Bioproducts, Qingdao Pilot National Laboratory for Marine Science and Technology, Qingdao 266237, China
3
Marine Natural Products R&D Laboratory, Qingdao Key Laboratory, Qingdao 266061, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2022, 20(4), 223; https://doi.org/10.3390/md20040223
Submission received: 21 February 2022 / Revised: 19 March 2022 / Accepted: 22 March 2022 / Published: 24 March 2022
Browse Figures
Versions Notes

Abstract

:
An immunomodulatory polysaccharide (DAP4) was extracted, purified, and characterized from Durvillaea antarctica. The results of chemical and spectroscopic analyses demonstrated that the polysaccharide was a fucoidan, and was mainly composed of (1→3)-α-l-Fucp and (1→4)-α-l-Fucp residues with a small degree of branching at C-3 of (1→4)-α-l-Fucp residues. Sulfate groups were at C-4 of (1→3)-α-l-Fucp, C-2 of (1→4)-α-l-Fucp and minor C-6 of (1→4)-β-d-Galp. Small amounts of xylose and galactose exist in the forms of β-d-Xylp-(1→ and β-d-Gal-(1→. The immunomodulatory activity of DAP4 was measured on RAW 264.7 cells, the results proved that DAP4 exhibited excellent immunomodulatory activities, such as promoted the proliferation of spleen lymphocytes, increased NO production, as well as enhanced phagocytic of macrophages. Besides, DAP4 could also produce better enhancement on the vitality of NK cells. For the high immunomodulatory activity, DAP4 might be a potential source of immunomodulatory fucoidan with a novel structure.

Graphical Abstract

1. Introduction

Seaweeds are rich in nutrients and bioactive compounds, sulfated polysaccharides are not only an important part of the cell wall, but also an important component with various biological activities. At present, sulfated polysaccharide is widely used in the food and pharmaceutical industries as it could be used as nutritional ingredient or therapeutic agent [1,2,3]. The algae polysaccharide possessed various biological activities, such as anti-tumor, immunomodulatory, anticoagulant, antioxidant, and anti-inflammatory [3,4,5,6]. Fucoidan is a kind of sulfated polysaccharide, consisting mainly of fucose and sulfate groups. Fucoidan was usually extracted from brown algae, sea cucumbers, and sea urchins. Commonly, fucoidan contains the main chain composed by 1,3-linked α-L-fucose residues, or a backbone consisted of alternating 1,3- and 1,4-linked α-L-fucose residues, with sulfate groups often occupying either the C-2, C-3, C-4, or a combination, positions [7]. Besides, fucoidan derived from brown alga is a complex branched polysaccharide, the side chains usually contain mannose, galactose, glucose, xylose, and uronic acid [8,9].
The immune system is the most effective defender against various pathogenic microbial infections before the adaptive immune system is activated [10]. It maintains the normal operation of the body and plays a vital role in human health through various cell types and a multitude of secreted factors [11,12]. The occurrence of many diseases, such as malignancies, bacterial, or viral infections, is closely related to immune disorders or immune deficiency. Sulfated polysaccharide has recently been cited as a potent immunomodulatory agent for treating these diseases [13].
Fucoidan has few side effects and has been proved to be a potential natural drug candidate in literature; besides, brown algae and marine invertebrates are the main sources of fucoidan [14]. Durvillaea antarctica, also known as cochayuyo and rimurapa, distributed along the coasts of Chile, southern New Zealand and Macquarie Island [15,16], is used in cuisine, and it also has medicinal values. D. antarctica typically contains around 11% protein, 65% carbohydrates, and 0.8–4.3% total lipids [17]. As previously reported, a soluble glucan extracted from D. antarctica has immunomodulatory activities, antioxidant activity, anti-viral activities, and anti-tumor activities, and the glucan consists of β-1,3- and β-1,6-glucose residues [18,19,20,21]. However, there are few reports about fucoidans extracted from D. Antarctica. A novel fucoidan isolated and purified from D. Antarctica could effectively promote the growth of leukocytes in the treatment of chemotherapy-treated mice was reported [22]. Up to date, there are few records of fucoidan prepared from D. Antarctica, its structural characteristics and biological activities have not been systematically studied. In the present work, we isolated and purified the fucoidan from brown algae D. Antarctica, and the structural characteristics were determined by methylation analysis and NMR spectrometry analysis. At the same time, its potential immunomodulatory activity in vitro was evaluated, including lymphocyte proliferation, phagocytic of macrophages, NO production, and NK cell cytotoxicity in vitro.

2. Results and Discussion

2.1. Chemical Characteristics of the Sulfated Polysaccharide DAP4

The crude polysaccharide was extracted from D. antarctica with hot water, the yield of fucoidan was 17.52% and designed as DAP. Then, the DAP was divided into four fractions by using a Q Sepharose Fast Flow column (Figure 1A). The chemical compositions of DAP and DAP1 to DAP4 were shown in Table 1. Composition analysis suggested that all fractions were heterogeneous polysaccharides, there were differences in the monosaccharide ratios, the molecular weight, and the degree of sulfation. DAP4 was further purified by gel filtration chromatography on a Sephacryl S-300/HR column and obtained as the major fraction. Compared with other fractions, DAP4 holds the highest sulfate content (22.3%) and fucose content (87.9%). As shown in Figure 1B, DAP4 contained fucose (Fuc), xylose (Xyl), galactose (Gal), and mannose (Man). DAP4 appeared as a single and symmetrical peak in the HPGPC chromatogram (Figure 1C), its average molecular weight was about 92 kDa according to its retention time in the HPGPC chromatogram. Like previous reports, fucoidan derived from brown seaweeds was usually combined with galactose, mannose, and uronic acids, in the form of galactofucan/fucogalactan, fucoglucuronomannan/glucuronofucans, and more complex heteropolysaccharide [7,23,24]. Thus, the fucoidan fraction DAP4 isolated from Durvillaea antarctica has a typical characteristic of fucoidan composition.
There are some characteristic peaks of functional groups in the FTIR spectrum (Figure 1D) of DAP4. The peaks at 3409 and 1054 cm−1 were from stretching vibration of O–H and C–O, respectively [25]. The peaks at 851 and 1245 cm−1 derived from the bending vibration of C–O–S of sulfate in axial position and stretching vibration of S–O of sulfate [26,27], respectively, suggesting the presence of sulfate ester in DAP. In addition, the peak at 1594 cm−1 was due to the bending vibration of O–H, the signal at 2917 cm−1 was due to the stretching vibration of C–H [28]. The peak at 1436 cm−1 corresponded to the absorption peak of variable angle vibration of the C–H bond.

2.2. Structural Characterization of DAP4

2.2.1. Methylation Analysis

Methylation analysis of DAP4 and its desulfated product DAP4 could provide information of the linkage pattern and sulfation position in DAP4. The results of the methylation analysis of DAP4 and DAP4-Ds are listed in Table 2. The results showed that the 2,4-di-O-methylfucitol, 2,3-di-O-methylfucitol, and 2-O-methylfucitol account for the main partially methylated alditol acetates, indicating that the major linkage type of DAP4 was (1→3), (1→4), and (1→3,4)-linked fucose units, respectively. After desulfation, the molecular ratio of 2,4-di-O-methylfucitol and 2,3-di-O-methylfucitol increased from 24.73% and 21.42% to 37.92% and 28.23%, respectively, while the amounts of 2-O-methylfucitol and 3-O-methylfucitol decreased drastically. Thus, it could be concluded that the sulfate esters were mainly substituted at the C-4 positions of the (1→3)-linked fucose unit and C-2 positions of (1→4)-linked fucose unit according to the variation of the proportions of the methylated derivatives. Furthermore, a certain amount of 2,3,4-tri-methylfucitol was detected, indicating the presence of terminal fucose units, and a minor amount of terminal xylose and galactose units, (1→4) and (1→4,6)-linked galactose units were also observed. Besides, the disappearance of (1→4,6)-linked galactose units in DAP4-Ds suggested that the sulfate ester might substitute at C-6 of (1→4)-linked galactose units. Total ion current chromatograms and MS spectrum of DAP4 and DAP4-Ds on GC-MS are shown in Figure S1A,B. The above results suggested that the linkages of DAP4 were mainly constituted of 3-linked α-l-fucopyranose residues, 4-linked α-l-fucopyranose residues, and little 4-linked β-d-galactopyranose residues, partially sulfated groups were at C-4 of (1→3)-linked fucose residues, C-2 of (1→4)-linked fucose residues, and C-6 of (1→4)-linked galactose residues. The fine structure was further confirmed by NMR.

2.2.2. NMR Analysis

The structural features of the polysaccharide DAP4 were further analyzed by 1D and 2D NMR spectra. In the 1H NMR spectrum of DAP4 (Figure 2A), the anomeric proton signals at 5.57, 5.50, 5.44, 5.34, and 5.16 ppm (labeled as A–F) were assigned to α-l-fucopyranose residues [29,30], while the high-field signal at 4.52 ppm (labeled as H) was assigned as β-d-galactopyranose residue [31]. Strong signals at 1.30 and 1.43 ppm were characteristic of H-6 of fucose residues, and the chemical shifts ranging from 4.70 to 3.60 ppm were designated as the protons present on C2–C6. In the 13C NMR spectrum (Figure 2B), the signals at 100.08, 99.20, 97.79, and 95.23 ppm were assigned to be anomeric carbon signals of fucose residues; the anomeric carbon signals at 104.70 and 110.16 ppm were assigned to galactose and terminal xylose residue, respectively. The signals at 62–83 ppm were attributed to the C-2−C-6 of the sugar residues. Moreover, the resonation of −CH3 at 17.22 ppm indicated the C-6 of the fucose residue.
The assignments of signal in 1H and 13C NMR spectra were carried out using two dimensional homonuclear 1H–1H COSY (Figure 2C), 1H–1H NOESY (Figure 2E), and heteronuclear 1H–13C HSQC (Figure 2D) experiments. According to the literature data of fucoidan from brown algae [32,33], the signals of DAP4 were assigned in Table 3. Most of the protons of the different linkage patterns in the HSQC spectrum were assigned, and because some of the proton signals overlapped, it was difficult to mark them in the spectrum.
The anomeric proton signal of residue A at 5.57 ppm correlated to the anomeric carbon signal at 100.08 ppm, while residue B at 5.50 ppm correlated to the C-1 signal at 95.23 ppm. Thus, the residues A and B were assigned to →4)-α-l-Fucp(2SO4)-(1→, →3)-α-l-Fucp(4SO4)-(1→ due to the downfield shifts of 82.29, 80.21/82.12, and 75.76 ppm at C-2, C-4, and C-3 ppm, respectively. The H-1 signal at 5.44 ppm of residue C correlated with the C-1 resonance at 97.79 ppm was attributed to disubstituted residue →2)-α-l-Fucp-(1→ for the downfield shift at 82.29 ppm of C-2. The H-1 signal at 5.34 ppm of residue E correlated with the C-1 resonance at 99.20 ppm was attributed to disubstituted residue →3)-α-l-Fucp-(1→ for the downfield shift at 77.94 ppm of C-3. Besides, the H-1 signals at 5.34 ppm of residue F and 5.16 ppm of residue G correlated to C-1 at 97.79 and 99.20 ppm were attributed to disubstituted residues →3,4)-α-l-Fucp-(1→ and →4)-α-l-Fucp-(1→ according to the downfield shifts at 77.94 and 78.32/79.95 ppm at C-3 and C-4 ppm, respectively.
The structural sequences analysis of different linkage patterns was assigned from the 1H-1H NOESY (Figure 2E) spectra. The H-1 of residue B showed correlation with H-4 of residue A, H-1 of C with H-4 of F, H-1of E with H-3 of E/F, and H-1 of G with H-3 of residues E and F. From these results, it could be deduced that the presence of sequences as follows: →3)-α-l-Fucp(4SO4)-(1→4)-α-l-Fucp(2SO4)-(1→, →2)-α-l-Fucp-(1→4)-α-l-Fucp-(1→, →3)-α-l-Fucp-(1→3)-α-l-Fucp-(1→, →3)-α-l-Fucp-(1→3,4)-α-l-Fucp-(1→, →4)-α-l-Fucp-(1→3)-α-l-Fucp-(1→ and →4)-α-l-Fucp-(1→3,4)-α-l-Fucp-(1→. Therefore, the results of methylation analysis and NMR showed that the fucoidan DAP4 from D. antarctica was not a regular polysaccharide.
According to previous studies, fucoidan derived from brown algae might consist of a similar backbone, which was alternating α-(1–3)- and α-(1–4)-l-fucose residues or repeated α-(1–3)-l-fucose residues. However, there were still many differences between the fucoidan from different materials, such as the sulfate group, side chains, sugar composition, and acetyl groups.
After a comprehensive analysis of spectral information, the primary structure of DAP4 was elucidated. As shown in Figure 3, DAP4 was a branched fucoidan, its backbone mainly consisted of →3)-α-l-Fucp-(1→, →3,4)-α-l-Fucp-(1→ and →4)-α-l-Fucp-(1→ residues with partial sulfation at the C-3 of →4)-α-l-Fucp-(1→, C-2 of →4)-α-l-Fucp-(1→ and C-6 of →4)-β-d-Galp-(1→. Its branches might contain fucose, galactose with or without sulfate ester. Similarly, the fucoidan(F4) from the D. antarctica reported by Yang, et al. [22] was mainly composed of fucose, galactose, and glucose in a molar ratio of 26.4:7.1:1.0. The backbone of F4 was composed of α-(1→3) and α-(1→4)-l-fucose residues with sulfate group at C-4 or C-2 positions and branched with α-l-fucose, β-d-galactose, and β-d-glucose residues. Until now, the structure information of fucoidan derived from the genus Durvillaea was seldom found. Matsuhiro et al. reported a sulfated fucose-containing polysaccharide containing 55.8% carbohydrate, 23.5% sulfate, and 4.22% uronic acids [34]. In contrast, the fucoidan from Cladosiphon okamuranus have a simply linear chain of α-(1→3)-l-fucose residues with sulfate groups at C-4 position [35]. The fucoidan from Sargassum horneri has a backbone consisting of alternating α-(1–3)- and α-(1–4)-l-fucose residues, however, the sulfate group mainly at C-3, and less at C-2 position, with side chain at C-4 of α-l-Fucp-(1→2)-α-l-Fucp-(1→residues [29]. The differences in structure, composition, molecular weight and sulfation of such polysaccharides might depend mainly on the following factors: the growth geographical environment, collection season, breeding conditions, and extraction method of the brown seaweed [36,37].
Fucoidan structures from various brown seaweeds have been studied in detail over the past two decades, and in general, have relatively similar and complex structures. They are usually divided into two types according to their backbones: alternating (1–3)- and (1–4)-l-fucose residues, or (1–3)-linked l-fucose residues. For both backbones, they possessed different sulfation patterns with one or two sulfate groups on C-2, C-4, or sometimes C-3 positions [38]. The bioactivity of brown seaweed fucoidan is closely related to their structural characteristics, especially their backbones and sulfation patterns [39]. The fucoidan DAP4 had different structure from other fucoidan from seaweed. The sulfate substitutions were located at the C-4 of→3)-α-l-Fucp-(1→, C-2 of →4)-α-l-Fucp-(1→ and minor C-6 of →4)-β-d-Galp-(1→; besides, the xylose existed only in the form of β-d-Xylp-(1→. Especially, the terminal β-d-xylosyl and →4)-β-d-Galp-(1→ residues were infrequently found in the fucoidan from Durvillaeaceae species [19,22,40].

2.3. Immunomodulatory Activity

2.3.1. Effects of DAP4 on RAW264.7 Cell Viability

MTT assay was used to investigate the effect of DAP4 on the cell viability of RAW264.7 macrophages. As shown in Figure 4A, DAP4 was not cytotoxic to RAW264.7 cells with a concentration range from 25 to 400 μg/mL. DAP4 could promote cell proliferation at 200 and 400 μg/mL, compared with the control group. In contrast, LNT was detected to show significant cytotoxicity when the concentration was higher than 200 μg/mL (p < 0.05). As a result, five distinct dosages of 25, 50, 100, 200, and 400 μg/mL were finally employed to evaluate the immune-enhancing activities of DAP4.

2.3.2. Effect of DAP4 on the Neutral Red Phagocytic Activity

Increased phagocytic activity was one of the most significant features of macrophage activation [41,42]. Accordingly, RAW 264.7 macrophages were pretreated with DAP4 at different concentrations, and their phagocytic activity was determined by the neutral red uptake method. As shown in Figure 4B, DAP4 could significantly enhance the phagocytic activity of RAW 264.7 cells in a dose-dependent manner (p < 0.05), as compared to the control group. Notably, the stimulatory effect of DAP4 on the phagocytic activity of RAW 264.7 macrophages was similar to that of LNT with the concentration at 400 μg/mL.

2.3.3. Effect of DAP4 on Lymphocyte Proliferation

The splenic lymphocytes play important roles in the cellular and humoral immune responses against the antigens in the blood. As lipopolysaccharide (LPS) could trigger the proliferation of B cells, and concanavalin A (ConA) could induce differentiation into T cells [43]. The effect of DAP4 on lymphocyte proliferation was investigated by MTT assay in the present work. As shown in Figure 5A, DAP4 could significantly enhance the proliferation of T lymphocytes stimulated with Con A (p < 0.05), the potential effect on T lymphocyte proliferation was comparable to that of LNT. Meanwhile, it was also observed that DAP4 could also improve the proliferation of B lymphocytes stimulated with LPS in a dose-dependent manner (Figure 5B), and the enhancing action of DAP4 was significantly stronger than that of LNT at different concentrations from 50 to 400 μg/mL. Our results indicated that the novel fucoidan DAP4 from D. antarctica could promote both T-cell–associated and B-cell-associated lymphocyte proliferation. Additionally, the results further confirmed that DAP4 has an ideal immunostimulatory activity.

2.3.4. Effect of DAP4 on the Production NO

NO is a vital bioactive molecule found throughout the body, its production is a critical component of the mammalian innate immune response [44,45]. To further compare the ability of DAP4 to cause NO production in macrophages, RAW264.7 cells were stimulated with DAP4 (25, 50, 100, 200, and 400 μg/mL), LPS (1 μg/mL), and LNT (100 μg/mL), respectively. As shown in Figure 6A, both polysaccharides increased NO production in RAW 264.7 macrophages dose-dependently (p < 0.05). NO productions of cells treated with DAP4 were higher than their production by control cells.

2.3.5. Effect of DAP4 on NK Cells Activity

NK cells are a very important part of the innate immune system, contributing to both anti-viral and anti-tumor immune responses [46]. MTT assay was used to determine the effect of DAP4 on the activity of NK cells. As shown in Figure 6B, DAP4 could significantly enhance NK cell viability at concentrations of 200 and 400 μg/mL compared with the control (p < 0.05), suggesting that enhancing NK cells viability is one of the ways DAP4 exerts immunomodulatory activity. Moreover, DAP4 showed stronger enhancing activity of NK cells than that of LNT at concentrations of 200 or 400 μg/mL.
From all the above results, DAP4 exhibited excellent immunomodulatory activity by promoting the proliferation of RAW 264.7 cells, promoting the proliferation of spleen T lymphocytes and B lymphocytes, increasing the production of NO and enhancing the phagocytic ability of macrophages. Besides, DAP4 could also enhance the activity of NK cells. Our findings may provide a basis for using the fucoidan from D. antarctica as an immunomodulator for pharmaceutical and food additive applications.
As previous studies reported, the mechanisms of sulfated polysaccharides exerting the immunomodulatory activity are related to the regulation of macrophage function, NK cells, and T/B lymphocytes, in addition to the stimulation of the immune responses of lymphocytes and the activation of the complement system [6]. Han et al. reported a fucoidan from Fucus vesiculosus possessing immunomodulatory activity because it could significantly increase the growth of B and T cells in a concentration-dependent manner [47]. Besides, the fucoidan from Kjellmaniella crassifolia and Undaria pinnatifida were also proved to have excellent immunomodulatory activity by stimulating macrophage cell proliferation and enhancing the secretion of various cytokines, such as granulocyte-macrophage colony-stimulating factor (GM-CSF) and TNF-α [48]. Taken together, fucoidan plays a crucial role in regulating our immune system, the action or mechanism is a complex process that might be regulated by many factors. Thus, the link between the immunomodulatory mechanisms and the structure characteristics of fucoidan requires further exploration.

3. Materials and Methods

3.1. Materials

Dry brown algae (Durvillaea antarctica) was provided by Gather Great Ocean Algae industry group CO., LTD (Qingdao, China). The raw material was milled into a powder and stored in a dry environment at room temperature. Q Sepharose Fast Flow and Sephacryl S-300/HR were purchased from GE Healthcare Life Sciences (Piscataway, NJ, USA). Pullulan standards for HPGPC analysis were purchased from Showa Denko K.K. (Tokyo, Japan). Monosaccharide standards for sugar composition analysis were purchased from Sigma (St. Louis, MO, USA). Pyromellitic acid (PMA), sodium fluoride (NaF), methyl iodide (CH3I), NaH, and KBr were also obtained from Sigma. Other materials, such as 732 cation-exchange resin, pyridine, and dimethylsulfoxide (DMSO), were from Signopharm Chemical Reagent CO., LTD (Shanghai, China).

3.2. Isolation and Purification of the Sulfated Polysaccharide

The isolation of crude polysaccharide was according to the method of Li, et al. [49]. Briefly, the powder of D. antarctica (500 g) was defatted by 95% ethanol with a ratio of 1:5 (w/v). Then the powder of D. antarctica was extracted with distilled water (5 L) at 70 °C for 3 h, the extraction was centrifuged at 5000 rpm for 10 min. This step was repeated three times. The supernatant was merged and concentrated under reduced pressure; next, the supernatant was dialyzed with cellulose membrane (molecular weight cut-off 3.5 kDa) against distilled water at room temperature. The recovered fraction was concentrated and precipitated by 95% ethanol, the final concentration of ethanol was 75%. The precipitate was washed with 100% ethanol and acetone to remove excess moisture, then the crude polysaccharide was dried at 40 °C. Finally, the dry polysaccharide was dissolved in distilled water to an appropriate concentration, mixed with 3 M CaCl2, then centrifuged at 5000 rpm for 10 min. The supernatant was lyophilized to obtain a crude fucoidan, designed as DAP.
The crude fucoidan DAP was separated by a Q Sepharose Fast Flow column (30 cm × 3.5 cm) and eluted with a step-wise gradient of NaCl (0, 0.5, 1.0, and 1.5 M). The fraction eluted with 1.5 M NaCl was collected, further purified on a Sephacryl S-300/HR column (100 cm × 2.5 cm), and eluted with 0.2 M NH4HCO3. The major polysaccharide fractions were pooled, desalted, freeze-dried, and named as DAP4.

3.3. Composition Analysis

The phenol-sulfuric acid method was used to determine the total sugar content using fucose as the standard [50]. Protein content was determined by the method of Bradford [51]. Sulfate ester content was measured by the barium rhodizonic acid method [52]. Uronic acid content was estimated by the carbazole-sulfuric acid method using glucuronic acid as the standard [53].
Reversed-phase high performance liquid chromatography (HPLC) after pre-column derivatization was used to analyze the monosaccharide composition [26,54]. Briefly, polysaccharide was hydrolyzed with 2 M trifluoroacetic acid at 105 °C for 6 h, then the dry hydrolysate was dissolved in 100 μL of distilled water and derivatized with 120 μL of 1- phenyl-3-methyl-5-pyrazolone (PMP) in methanol. The mixture was added to 100 μL of 0.3 M HCl solution and vigorously shaken and centrifuged. The supernatant was filtered through 0.22 μm nylon membranes, and the resulting solution was injected into the XDB-C18 column (4.6 mm × 250 mm). The chromatogram was performed on an Agilent 1260 Infinity HPLC instrument fitted with an Agilent XDB-UV detector (254 nm, Palo Alto, USA). The mobile phase was a mixture of 0.1 M KH2PO4 (pH 6.7)-acetonitrile (83:17). The flow rate was 1.0 mL/min and column temperature was 30 °C. Identification of sugar was done by comparison with retention time of reference sugars (l-rhamnose, l-arabinose, d-xylose, l-fucose, d-mannose, d-galactose, d-glucose, d-glucuronic acid, d-galacturonic acid, d-glucosamine). The sugar content was calculated by the ratio of the peak areas of sugar and correspondent reference sugar [54].

3.4. Purity and Molecular Weight

Purity and molecular weight of polysaccharide were assessed by high performance gel permeation chromatography (HPGPC) [54]. The assay was performed on an Agilent 1260 Infinity HPLC instrument fitted with a Shodex OHpak SB-804 HQ column (8.0 mm × 300 mm, Tokyo, Japan) and elution with 0.2 mol/L Na2SO4 at a flow rate of 0.5 mL/min. The signals were measured using a refractive index detector (Agilent RID-10A Series). The molecular weight was estimated by reference to a calibration curve made by pullulan standards; molecular weights of pullulan standards were 5.9, 9.6, 21.1, 47.1, 107, 200, 344, and 708 kDa, respectively.

3.5. Desulfation and Methylation Analysis

To compare the methylation-analysis data of sulfated polysaccharide with its desulfated form could provide clearer information about the sulfate group. Desulfation was performed as previously described [54]. Briefly, DAP4 (200 mg) was dissolved in water and passed through an ion-exchange column (732 resin, H+ form), which was eluted with distilled water. The combined effluent was neutralized with pyridine to pH 9.0, and then lyophilized to give a white powdered pyridinium salt. The product was dissolved in dimethyl sulfoxide (12 mL) containing pyromellitic acid (124 mg) and NaF (120 mg), pyridine (4 mL) was added, and then the solution was shaken at 100 °C for 4 h. After the reaction was completed, the product was dialyzed against distilled water, freeze-dried, and designated as DAP4-Ds. The completeness of desulfation was assayed by sulfate ester content of the polysaccharide.
Methylation analysis was performed according to the method of Hakomori with some modifications [55]. Polysaccharide (2 mg) was dissolved in DMSO (0.6 mL) and anhydrous NaH (100–200 mg) was then added and the mixture was stirred under N2 at 60 °C for 1.5 h. Methyl iodide was then added to the mixture and stirred for a further 1.5 h. The reaction was terminated by adding 1 mL distilled water, and the residue was extracted with CHCl3. The extract was washed with distilled water and evaporated to dryness. The completion of methylation was confirmed by IR spectroscopy as the disappearance of −OH bands. Methylated samples were hydrolyzed with 2 M trifluoroacetic acid at 105 °C for 6 h. The methylated products were converted into their corresponding alditols by reduction with NaBD4 and acetylated. Thereafter, partial methylated alditol acetates were analyzed by gas chromatography–mass spectrometry (GC–MS) on a TRACE 1300-ISQ instrument (Thermo Scientific, Waltham, MA, USA) fitted with a DB 225 fused silica capillary column (0.25 mm × 30 mm, Agilent Technologies, Santa Clara, CA, USA). The partially methylated alditol acetates were identified according to the Complex Carbohydrate Structural Database of the Complex Carbohydrate Research Centre (https://glygen.ccrc.uga.edu/, accessed on 21 September 2021).

3.6. Spectroscopy Analysis

FTIR spectra of DAP4 were measured on a Nicolet Nexus 470 spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). DAP4 and DAP4-Ds (2.0 mg) were mixed with KBr powder, ground, and pressed into a 1 mm pellet for FTIR measurements, KBr blank film was used as a control group. The frequency range was 4000–400 cm−1 and scanning number was 32 times.
NMR analyses of DAP4 was performed on an Agilent DD2 500 MHz NMR spectrometer (Agilent Technologies, Santa Clara, CA, USA). The temperature was 25 °C. Briefly, DAP4 (50 mg) was dissolved in 500 μL of D2O and freeze-dried. The operation was repeated three times. Finally, DAP4 was redissolved in 500 μL D2O and transferred into NMR tube. The internal standard was acetone (1H 2.225 ppm, 13C 31.07 ppm). Spectra were processed and analyzed by MestReNova (V12.0.3, Mestrelab Research, Spain).

3.7. Immunomodulatory Activity

3.7.1. Cell Cultures

RAW264.7 cells, a line from murine macrophages were from ATCC (Manassas, VA, USA, CVCL_0493). RAW264.7 cells were cultured in RPMI-1640 medium supplemented with 10% (v/v) FBS. Besides, penicillin (100 U/mL) and streptomycin sulfate (100 μg/mL) were added to the medium. Cells were incubated at 37 °C in a humidified incubator with 5% CO2. Before plating, cells were digested by 0.25% pancreatin and washed with PBS, cells were plated on 6- or 96-well plates for the following experiments.

3.7.2. Cytotoxicity Assay

Cytotoxicity of DAP4 was measured by MTT assay. Briefly, RAW264.7 cells were seeded on 96-well plates. After incubating at 37 °C for 24 h, cells were exposed to different concentrations of DAP4 (25, 50, 100, 200, and 400 μg/mL) and lentinan (LNT) for 24 h at 37 °C. After that time, 20 μL of MTT solution (5 mg/mL in PBS) was added to each well, and incubated for 4h. Finally, the medium was removed and 150 μL DMSO was added to dissolve the formazan salt. The absorbance was tested at 570 nm on a Bio-Rad model 680 Microplate Reader (Hercules, CA, USA).

3.7.3. Neutral Red Phagocytosis Assay

The pinocytosis activity of RAW264.7 cells was measured by neutral red uptake assay according to the method of Yang et al. [21]. Briefly, RAW264.7 cells were seeded on 96-well plates, after incubating at 37 °C for 24 h, cells were exposed to different concentrations of DAP4 (25, 50, 100, 200, and 400 μg/mL), and LNT (1–100 μg/mL) for 24 h. After that time, the cell culture medium was removed and 100 μL of 0.075% neutral red was added into each well. After being incubated at 37 °C for 0.5 h, cells were washed with PBS three times. Furthermore, 150 μL of cell lysate containing of acetic acid and ethanol (v/v, 1:1) were added to each well and incubated at 4 °C for another 0.5 h. Finally, the absorbance was tested on the Bio-Rad model 680 Microplate Reader at 570 nm.

3.7.4. NO Production Assay

NO production was measured by Griess assay according to the method of Zhao et al. [56]. Briefly, RAW264.7 cells were seeded on 96-well plates and incubated at 37 °C for 12 h, cells were treated with LPS (1 μg/mL) or DAP4 (25, 50, 100, 200, and 400 μg/mL) at 37 ℃ for 24 h. After that, the supernatant was collected and used to measure the content of NO in the supernatant. The supernatant (50 μL) was added to the mixture of 50 μL Griess reagent I (1% sulfanilamide dihydrochloride) and Griess reagent II (0.1% naphthyl ethylenediamine dihydrochloride) at the ratio of 1:1. After being incubated at room temperature for 0.5 h, the absorbance at 540 nm was measured on the Bio-Rad model 680 Microplate Reader. NaNO2 was used as a standard, cells without any treatment were used as the negative control while LPS-treated cells were a positive control.

3.7.5. Lymphocyte Proliferation Assay

The splenocyte proliferation was evaluated by MTT-based colorimetric assay as previously described [57]. Briefly, the spleens of BALB/c mice (male, 8–10 weeks old) were removed aseptically. Spleen cells of mice were obtained by gently teasing the organ in RPMI-1640 medium under aseptic condition and centrifuged at 1000 rpm for 10 min. Splenic T- and B-lymphocyte proliferation was induced with the mitogens ConA and LPS, respectively [58]. Hemolytic Gey’s solution was used to remove the red blood cells. Then spleen cells were resuspended in complete RPMI 1640 medium and were plated on 96- well culture platers with ConA (2.5 μg/mL) or LPS (10 μg/mL). After the cells were cultured with or without DAP4 (25, 50, 100, 200, and 400 μg/mL) at 37 °C in a humidified atmosphere containing 5% CO2 for 48 h, 20 μL MTT (5 mg/mL) were added to each well and incubated for another 4 h. Finally, the medium was removed, 150 μL DMSO was added to dissolve the formazan salt. The absorbance was tested at 570 nm on a Bio-Rad model 680 Microplate Reader.

3.7.6. NK Cells Activity Assay

The cytolytic activity of NK cells was detected by a standard 51Cr release assay according to the method of Zhao et al. [56]. Briefly, 100 μL of splenocytes were seeded into 96-well plate and used as effector cells, then 100 μL of LNT was added to a final concentration of 50 μg/mL. Furthermore, 100 μL of RPMI-1640 medium was added and used as control group, or 100 μL of DAP were added. Then the cells were incubated at 37 °C in a 5% CO2 incubator. The target cells, YAC-1 from ATCC (Manassas, VA, USA, CVCL_2244), were added at an effector-to-target at a ratio of 10:1. After incubation for another 4 h, 20 µL of MTT (5 mg/mL) was added, and the cells were also incubated for 4 h. The medium was removed and 150 μL DMSO was added to dissolve the formazan salt. The absorbance was tested at 570 nm on a Bio-Rad model 680 Microplate Reader. The cytotoxicity of NK cells was calculated using the following formula: NK cell cytotoxicity (%) = 1 − (OD2 − OD3) / OD1 × 100% (OD1: OD value of target cells control; OD2: OD value of test group; OD3: OD value of the effector cells group).

3.8. Statistical Analysis

All bioassay values were expressed as means ± standard deviation (SD). At least three samples were prepared for assays of every attribute. The experimental data were subjected to one-way ANOVA test (GraphPad Prism 7.00, La Jolla, CA, USA). Statistical significance was denoted by asterisks and hashes. * and # represented p < 0.05, while ** and ## were p < 0.01.

4. Conclusions

In conclusion, a fucoidan DAP4 was extracted, purified, and characterized from the brown seaweed D. antarctica. The backbone of DAP4 consists of (1→3)-α-l-Fucp and (1→4)-α-l-Fucp residues with a small degree of branching at C-3 of (1→4)-α-l-Fucp residues, which contained fucose, galactose with or without sulfate ester. About 22.30% of the total number of sugar residues in DAP4 was substituted by sulfate groups, and sulfate groups were at C-3 of (1→4)-α-l-Fucp, C-2 of (1→4)-α-l-Fucp and minor C-6 of (1→4)-β-d-Galp. Immunomodulatory activities in vitro demonstrated that DAP4 exhibited excellent immunomodulatory activity by promoting the proliferation of RAW264.7 cells, promoting the proliferation of spleen lymphocytes, exceeding NO production, and enhancing phagocytic of macrophages. Besides, DAP4 could also produce better enhancement on the vitality of NK cells. DAP4 had high immune-enhancing activity and might be a potential source of immunomodulatory fucoidan with a novel structure. Further analysis on the structure–activity relationship of the marine algal fucoidan would play an important role in the understanding of immunomodulatory properties. The detailed mechanism of immunomodulatory action of DAP4 is currently still being investigated.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md20040223/s1, Figure S1: Total ion current (TIC) chromatograms of DAP4 and DAP4-Ds on GC–MS and mass spectra; Figure S2: MS of partial O-methylated alditol acetates from DAP4 and its desulfation form, DAP4-Ds.

Author Contributions

L.Q.: conceptualization, data curation, software, writing—original draft; H.X.: investigation, validation; Y.H.: formal analysis; C.L.: data curation, methodology; K.W.: software, data curation; J.C.: data curation, methodology; C.Q.: formal analysis, supervision, project administration; J.M.: supervision, project administration, writing—review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Key Research and Development Program of China (2018YFD09000705), Basic Scientific Fund for National Public Research Institutes of China (2020Q02), Natural Science Foundation of China (32000074, 42176130), Natural Science Foundation of Shandong (ZR202102190351, ZR2019BD023), Tai Mountain Industry Leading Talent of Shan Dong (2019TSCYCX-06), Science and Technology Planning Project of Guangxi (AA21196002), and Postdoctoral Applied Research Projects of Qingdao (QDBSH202103).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding authors.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Manlusoc, J.K.; Hsieh, C.-L.; Hsieh, C.-Y.; Salac, E.S.; Lee, Y.-T.; Tsai, P.-W. Pharmacologic application potentials of sulfated polysaccharide from marine algae. Polymers 2019, 11, 7. [Google Scholar]
  2. Xu, S.-Y.; Huang, X.; Cheong, K.-L. Recent advances in marine algae polysaccharides: Isolation, structure, and activities. Mar. Drugs 2017, 15, 12. [Google Scholar]
  3. Wijesinghe, W.A.J.P.; Jeon, Y.-J. Biological activities and potential industrial applications of fucose rich sulfated polysaccharides and fucoidans isolated from brown seaweeds: A review. Carbohydr. Polym. 2012, 88, 13–20. [Google Scholar]
  4. Gong, Y.; Ma, Y.; Cheung, P.C.-K.; You, L.; Liao, L.; Pedisić, S.; Kulikouskaya, V. Structural characteristics and anti-inflammatory activity of UV/H2O2-treated algal sulfated polysaccharide from Gracilaria lemaneiformis. Food Chem. Toxicol. 2021, 152, 112157. [Google Scholar] [PubMed]
  5. Hans, N.; Malik, A.; Naik, S. Antiviral activity of sulfated polysaccharides from marine algae and its application in combating COVID-19: Mini review. Bioresour. Technol. Rep. 2021, 13, 100623. [Google Scholar]
  6. Huang, L.; Shen, M.; Morris, G.A.; Xie, J. Sulfated polysaccharides: Immunomodulation and signaling mechanisms. Trends Food Sci. Technol. 2019, 92, 1–11. [Google Scholar]
  7. Zvyagintseva, T.N.; Usoltseva, R.V.; Shevchenko, N.M.; Surits, V.V.; Imbs, T.I.; Malyarenko, O.S.; Besednova, N.N.; Ivanushko, L.A.; Ermakova, S.P. Structural diversity of fucoidans and their radioprotective effect. Carbohydr. Polym. 2021, 273, 118551. [Google Scholar]
  8. Bilan, M.I.; Grachev, A.A.; Shashkov, A.S.; Thuy, T.T.T.; Van, T.T.T.; Ly, B.M.; Nifantiev, N.E.; Usov, A.I. Preliminary investigation of a highly sulfated galactofucan fraction isolated from the brown alga Sargassum polycystum. Carbohydr. Res. 2013, 377, 48–57. [Google Scholar]
  9. Bilan, M.I.; Shashkov, A.S.; Usov, A.I. Structure of a sulfated xylofucan from the brown alga Punctaria plantaginea. Carbohydr. Res. 2014, 393, 1–8. [Google Scholar]
  10. Zhou, S.; Li, Q.; Wu, H.; Lu, Q. The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases. Cell Mol. Immunol 2020, 17, 335–346. [Google Scholar]
  11. Mogensen, T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol Rev. 2009, 22, 240–273. [Google Scholar] [PubMed] [Green Version]
  12. Taha, Z.; van Rensburg, J.H.J.; Yang, X. The Hippo Pathway: Immunity and cancer. Cancers 2018, 10, 94. [Google Scholar]
  13. Yu, J.; Dong, X.-D.; Jiao, J.-S.; Ji, H.-Y.; Liu, A.-J. Antitumor and immunoregulatory activities of a novel polysaccharide from Astragalus membranaceus on S180 tumor-bearing mice. Int. J. Biol. Macromol. 2021, 189, 930–938. [Google Scholar] [PubMed]
  14. Zayed, A.; Ulber, R. Fucoidan production: Approval key challenges and opportunities. Carbohydr. Polym. 2019, 211, 289–297. [Google Scholar]
  15. Smith, J.M.B.; Bayliss-Smith, T.P. Kelp-plucking: Coastal erosion facilitated by bull-kelp Durvillaea antarctica at subantarctic Macquarie Island. Antarct. Sci. 1998, 10, 431–438. [Google Scholar]
  16. Parvizi, E.; Craw, D.; Waters, J.M. Kelp DNA records late Holocene paleoseismic uplift of coastline, southeastern New Zealand. Earth Planet. Sci. Lett. 2019, 520, 18–25. [Google Scholar]
  17. Quiñones, J.; Díaz, R.; Dantagnan, P.; Hernández, A.; Valdes, M.; Lorenzo, J.M.; Cancino, D.; Sepúlveda, N.; Farías, J.G. Dietary inclusion of Durvillaea antarctica meal and rapeseed (Brassica napus) oil on growth, feed utilization and fillet quality of rainbow trout (Oncorhynchus mykiss ). Aquaculture 2021, 530, 735882. [Google Scholar]
  18. Castillo, E.; Duarte, L.F.; Corrales, N.; Álvarez, D.M.; Farías, M.A.; Henríquez, A.; Smith, P.C.; Agurto-Muñoz, C.; González, P.A. Anti-herpetic activity of macrocystis pyrifera and Durvillaea antarctica algae extracts against HSV-1 and HSV-2. Front. Microbiol 2020, 11, 2006. [Google Scholar]
  19. He, J.; Xu, Y.; Chen, H.; Sun, P. Extraction, structural characterization, and potential antioxidant activity of the polysaccharides from four seaweeds. Int. J. Mol. Sci. 2016, 17, 1988. [Google Scholar]
  20. Su, F.; Song, Q.; Zhang, C.; Xu, X.; Li, M.; Yao, D.; Wu, L.; Qu, X.; Guan, H.; Yu, G.; et al. A β-1,3/1,6-glucan from Durvillaea Antarctica inhibits tumor progression in vivo as an immune stimulator. Carbohydr. Polym. 2019, 222, 114993. [Google Scholar]
  21. Yang, Y.; Zhao, X.; Li, J.; Jiang, H.; Shan, X.; Wang, Y.; Ma, W.; Hao, J.; Yu, G. A beta-glucan from Durvillaea Antarctica has immunomodulatory effects on RAW264.7 macrophages via toll-like receptor 4. Carbohydr. Polym. 2018, 191, 255–265. [Google Scholar] [PubMed]
  22. Yang, Y.; Hu, T.; Li, J.; Xin, M.; Zhao, X. Structural characterization and effect on leukopenia of fucoidan from Durvillaea antarctica. Carbohydr. Polym. 2021, 256, 117529. [Google Scholar] [PubMed]
  23. Ponce, N.M.A.; Flores, M.L.; Pujol, C.A.; Becerra, M.B.; Navarro, D.A.; Cordoba, O.; Damonte, E.B.; Stortz, C.A. Fucoidans from the phaeophyta Scytosiphon lomentaria: Chemical analysis and antiviral activity of the galactofucan component. Carbohydr. Res. 2019, 478, 18–24. [Google Scholar] [PubMed]
  24. Wang, P.; Zhao, X.; Lv, Y.; Liu, Y.; Lang, Y.; Wu, J.; Liu, X.; Li, M.; Yu, G. Analysis of structural heterogeneity of fucoidan from Hizikia fusiforme by ES-CID-MS/MS. Carbohydr. Polym. 2012, 90, 602–607. [Google Scholar] [PubMed]
  25. Mathlouthi, M.; Koenig, J.L. Vibrational Spectra of Carbohydrates. In Advances in Carbohydrate Chemistry and Biochemistry; Tipson, R.S., Horton, D., Eds.; Academic Press: Cambridge, MA, USA, 1987; Volume 44, pp. 7–89. [Google Scholar]
  26. Liu, X.; Hao, J.; He, X.; Wang, S.; Cao, S.; Qin, L.; Mao, W. A rhamnan-type sulfated polysaccharide with novel structure from Monostroma angicava Kjellm (Chlorophyta) and its bioactivity. Carbohydr. Polym. 2017, 173, 732–748. [Google Scholar]
  27. Pereira, L.; Amado, A.M.; Critchley, A.T.; van de Velde, F.; Ribeiro-Claro, P.J.A. Identification of selected seaweed polysaccharides (phycocolloids) by vibrational spectroscopy (FTIR-ATR and FT-Raman). Food Hydrocoll. 2009, 23, 1903–1909. [Google Scholar]
  28. Mitić, Ž.; Cakić, M.; Nikolić, G.M.; Nikolić, R.; Nikolić, G.S.; Pavlović, R.; Santaniello, E. Synthesis, physicochemical and spectroscopic characterization of copper(II)-polysaccharide pullulan complexes by UV–vis, ATR-FTIR, and EPR. Carbohydr. Res. 2011, 346, 434–441. [Google Scholar]
  29. Silchenko, A.S.; Rasin, A.B.; Kusaykin, M.I.; Kalinovsky, A.I.; Miansong, Z.; Changheng, L.; Malyarenko, O.; Zueva, A.O.; Zvyagintseva, T.N.; Ermakova, S.P. Structure, enzymatic transformation, anticancer activity of fucoidan and sulphated fucooligosaccharides from Sargassum horneri. Carbohydr. Polym. 2017, 175, 654–660. [Google Scholar]
  30. He, W.; Sun, H.; Su, L.; Zhou, D.; Zhang, X.; Shanggui, D.; Chen, Y. Structure and anticoagulant activity of a sulfated fucan from the sea cucumber Acaudina leucoprocta. Int. J. Biol. Macromol. 2020, 164, 87–94. [Google Scholar]
  31. Li, N.; Mao, W.; Yan, M.; Liu, X.; Xia, Z.; Wang, S.; Xiao, B.; Chen, C.; Zhang, L.; Cao, S. Structural characterization and anticoagulant activity of a sulfated polysaccharide from the green alga Codium divaricatum. Carbohydr. Polym. 2015, 121, 175–182. [Google Scholar]
  32. Bilan, M.I.; Ustyuzhanina, N.E.; Shashkov, A.S.; Thanh, T.T.T.; Bui, M.L.; Tran, T.T.V.; Bui, V.N.; Nifantiev, N.E.; Usov, A.I. A sulfated galactofucan from the brown alga Hormophysa cuneiformis (Fucales, Sargassaceae). Carbohydr. Res. 2018, 469, 48–54. [Google Scholar] [PubMed]
  33. Bilan, M.I.; Grachev, A.A.; Shashkov, A.S.; Kelly, M.; Sanderson, C.J.; Nifantiev, N.E.; Usov, A.I. Further studies on the composition and structure of a fucoidan preparation from the brown alga Saccharina latissima. Carbohydr. Res. 2010, 345, 2038–2047. [Google Scholar] [PubMed]
  34. Matsuhiro, B.; Zu, I.E.; Jashes, M. Sulfated polysaccharides from Durvillaea antarctica. Hydrobiologia 1996, 321, 77–81. [Google Scholar]
  35. Lim, S.J.; Wan, A.W.M.; Schiehser, S. Structural elucidation of fucoidan from Cladosiphon okamuranus (Okinawa mozuku). Food Chem. 2019, 272, 222–226. [Google Scholar] [PubMed]
  36. Mak, W.; Hamid, N.; Liu, T. Fucoidan from New Zealand Undaria pinnatifida: Monthly variations and determination of antioxidant activities. Carbohydr. Polym. 2013, 95, 606–614. [Google Scholar] [PubMed]
  37. Liu, X.; Xi, X.; Jia, A.; Zhang, M.; Cui, T.; Bai, X.; Shi, Y.; Liu, C. A fucoidan from Sargassum fusiforme with novel structure and its regulatory effects on intestinal microbiota in high-fat diet-fed mice. Food Chem. 2021, 358, 129908. [Google Scholar] [PubMed]
  38. Wu, L.; Sun, J.; Su, X.; Yu, Q.; Yu, Q.; Zhang, P. A review about the development of fucoidan in antitumor activity: Progress and challenges. Carbohydr. Polym. 2016, 154, 96–111. [Google Scholar] [PubMed]
  39. Wen, Y.; Gao, L.; Zhou, H.; Ai, C.; Huang, X.; Wang, M.; Zhang, Y.; Zhao, C. Opportunities and challenges of algal fucoidan for diabetes management. Trends Food Sci. Technol. 2021, 111, 628–641. [Google Scholar]
  40. Lorbeer, A.J.; Charoensiddhi, S.; Lahnstein, J.; Lars, C.; Franco, C.M.M.; Bulone, V.; Zhang, W. Sequential extraction and characterization of fucoidans and alginates from Ecklonia radiata, Macrocystis pyrifera, Durvillaea potatorum, and Seirococcus axillaris. J. Appl. Phycol. 2017, 29, 1515–1526. [Google Scholar]
  41. Sun, H.; Zhang, J.; Chen, F.; Chen, X.; Zhou, Z.; Wang, H. Activation of RAW264.7 macrophages by the polysaccharide from the roots of Actinidia eriantha and its molecular mechanisms. Carbohydr. Polym. 2015, 121, 388–402. [Google Scholar]
  42. Schepetkin, I.A.; Quinn, M.T. Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential. Int. Immunopharmacol. 2006, 6, 317–333. [Google Scholar] [PubMed]
  43. Flaminio, M.J.B.F.; Antczak, D.F. Inhibition of lymphocyte proliferation and activation: A mechanism used by equine invasive trophoblast to escape the maternal immune response. Placenta 2005, 26, 148–159. [Google Scholar] [PubMed]
  44. Fang, F.C. Antimicrobial reactive oxygen and nitrogen species: Concepts and controversies. Nat. Rev. Microbiol. 2004, 2, 820–832. [Google Scholar] [PubMed]
  45. Vazquez-Torres, A.; Stevanin, T.; Jones-Carson, J.; Castor, M.; Read, R.C.; Fang, F.C. Chapter 26-Analysis of nitric oxide-dependent antimicrobial actions in macrophages and mice. In Methods in Enzymology; Poole, R.K., Ed.; Academic Press: Cambridge, MA, USA, 2008; Volume 437, pp. 521–538. [Google Scholar]
  46. Cerwenka, A.; Lanier, L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunololy 2001, 1, 41–49. [Google Scholar]
  47. Han, J.G.; Syed, A.Q.; Kwon, M. Antioxident, immunomodulatory and anticancer activity of fucoidan isolated from Fucus vesiculosus. J. Biotechnol. 2008, 136, S571. [Google Scholar]
  48. Peng, Y.; Song, Y.; Wang, Q. In vitro and in vivo immunomodulatory effects of fucoidan compound agents. Int. J. Biol. Macromol. 2019, 127, 48–56. [Google Scholar]
  49. Li, B.; Wei, X.-J.; Sun, J.-L.; Xu, S.-Y. Structural investigation of a fucoidan containing a fucose-free core from the brown seaweed, Hizikia fusiforme. Carbohydr. Res. 2006, 341, 1135–1146. [Google Scholar]
  50. DuBois, M.; Gilles, K.A.; Hamilton, J.K.; Rebers, P.A.; Smith, F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 1956, 28, 350–356. [Google Scholar]
  51. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar]
  52. Terho, T.T.; Hartiala, K. Method for determination of the sulfate content of glycosaminoglycans. Anal. Biochem. 1971, 41, 471–476. [Google Scholar]
  53. Bitter, T.; Muir, H.M. A modified uronic acid carbazole reaction. Anal. Biochem. 1962, 4, 330–334. [Google Scholar]
  54. Qin, L.; He, M.; Yang, Y. Anticoagulant-active sulfated arabinogalactan from Chaetomorpha linum: Structural characterization and action on coagulation factors. Carbohydr. Polym. 2020, 242, 116394. [Google Scholar]
  55. Harris, P.J.; Henry, R.J.; Blakeney, A.B.; Stone, B.A. An improved procedure for the methylation analysis of oligosaccharides and polysaccharides. Carbohydr. Res. 1984, 127, 59–73. [Google Scholar]
  56. Zhao, X.; Jiao, G.; Yang, Y. Structure and immunomodulatory activity of a sulfated agarose with pyruvate and xylose substitutes from Polysiphonia senticulosa Harvey. Carbohydr. Polym. 2017, 176, 29–37. [Google Scholar]
  57. Lysle, D.T.; Coussons, M.E.; Watts, V.J.; Bennett, E.H.; Dykstra, L.A. Morphine-induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 1993, 265, 1071. [Google Scholar]
  58. Bi, H.; Han, H.; Li, Z.; Ni, W.; Chen, Y.; Zhu, J.; Gao, T.; Hao, M.; Zhou, Y. A water-soluble polysaccharide from the fruit bodies of Bulgaria inquinans (Fries) and its anti-malarial activity. Evid. Based Complement. Altern. Med. 2011, 2011, 973460. [Google Scholar]
Marinedrugs 20 00223 g001 550
Figure 1. Q Sepharose Fast Flow column, HPLC chromatograms, and IR spectrum of DAP4. (A) The crude polysaccharide was separated by a Q Sepharose Fast Flow column.; (B) monosaccharide composition analysis of DAP4; (C) HPGPC chromatogram of DAP4 and the standard curve of molecular weight; and (D) IR spectrum of DAP4.
Figure 1. Q Sepharose Fast Flow column, HPLC chromatograms, and IR spectrum of DAP4. (A) The crude polysaccharide was separated by a Q Sepharose Fast Flow column.; (B) monosaccharide composition analysis of DAP4; (C) HPGPC chromatogram of DAP4 and the standard curve of molecular weight; and (D) IR spectrum of DAP4.
Marinedrugs 20 00223 g001
Marinedrugs 20 00223 g002a 550Marinedrugs 20 00223 g002b 550Marinedrugs 20 00223 g002c 550
Figure 2. NMR spectra of DAP4. Spectra were performed on an Agilent DD2 500 MHz NMR spectrometer using acetone as internal standard. (A) 1H NMR spectrum; (B) 13C spectrum; (C) 1H–1H COSY spectrum; (D) 1H–13C HSQC spectrum; (E) 1H–1H NOESY spectrum. A–H correspond to →4)-α-l-Fucp(2SO4)-(1→, →3)-α-l-Fucp(4SO4)-(1→, →2)-α-l-Fucp-(1→, β-d-Xylp-(1→, →3)-α-l-Fucp-(1→, →3,4)-α-l-Fucp-(1→, →4)-α-l-Fucp-(1→ and β-d-Galp-(1→.
Figure 2. NMR spectra of DAP4. Spectra were performed on an Agilent DD2 500 MHz NMR spectrometer using acetone as internal standard. (A) 1H NMR spectrum; (B) 13C spectrum; (C) 1H–1H COSY spectrum; (D) 1H–13C HSQC spectrum; (E) 1H–1H NOESY spectrum. A–H correspond to →4)-α-l-Fucp(2SO4)-(1→, →3)-α-l-Fucp(4SO4)-(1→, →2)-α-l-Fucp-(1→, β-d-Xylp-(1→, →3)-α-l-Fucp-(1→, →3,4)-α-l-Fucp-(1→, →4)-α-l-Fucp-(1→ and β-d-Galp-(1→.
Marinedrugs 20 00223 g002aMarinedrugs 20 00223 g002bMarinedrugs 20 00223 g002c
Marinedrugs 20 00223 g003 550
Figure 3. Tentative structure of DAP4 from Durvillaea antarctica.
Figure 3. Tentative structure of DAP4 from Durvillaea antarctica.
Marinedrugs 20 00223 g003
Marinedrugs 20 00223 g004 550
Figure 4. Effects of DAP4 on RAW264.7 cell viability (A), and neutral red phagocytic (B). * p < 0.05, ** p < 0.01 versus the control group.
Figure 4. Effects of DAP4 on RAW264.7 cell viability (A), and neutral red phagocytic (B). * p < 0.05, ** p < 0.01 versus the control group.
Marinedrugs 20 00223 g004
Marinedrugs 20 00223 g005 550
Figure 5. Effects of DAP4 on splenic T lymphocyte proliferation (A), splenic B lymphocyte proliferation (B). * p < 0.05, ** p < 0.01, versus with control group; # p < 0.05, versus the ConA or LPS groups.
Figure 5. Effects of DAP4 on splenic T lymphocyte proliferation (A), splenic B lymphocyte proliferation (B). * p < 0.05, ** p < 0.01, versus with control group; # p < 0.05, versus the ConA or LPS groups.
Marinedrugs 20 00223 g005
Marinedrugs 20 00223 g006 550
Figure 6. Effects of DAP4 on (A) NO production of RAW264.7 macrophages, and (B) NK cell viability. All values are expressed as means ± SD of three independent experiments. * p < 0.05. ** p < 0.01 compared with the control group.
Figure 6. Effects of DAP4 on (A) NO production of RAW264.7 macrophages, and (B) NK cell viability. All values are expressed as means ± SD of three independent experiments. * p < 0.05. ** p < 0.01 compared with the control group.
Marinedrugs 20 00223 g006
Table
Table 1. Composition analysis of polysaccharide isolated from D. antarctica.
Table 1. Composition analysis of polysaccharide isolated from D. antarctica.
SampleTotal Sugar
(%)		Protein
(%)		Sulfate
(%)		Mw (kDa)Monosaccharide Composition (Molar Ratio %)
ManGlcAGlcGalXylFuc
DAP69.83.420.7nd9.711.819.718.15.934.8
DAP178.22.14.57549.2nd a82.13.4nd a5.3
DAP276.71.015.653223.50.923.79.56.835.6
DAP382.3nd17.736817.82.34.332.14.239.3
DAP475.90.222.3922.91.2nd a3.54.587.9
a not detected.
Table
Table 2. Methylation analyses of DAP4 and DAP4-Ds.
Table 2. Methylation analyses of DAP4 and DAP4-Ds.
Methylate Alditol AcetateMolar Percent RatioLinkage Pattern
DAP4DAP4-Ds
1,5-Di-O-acrtyl-2,3,4-tri-O-methyl-d-xylitol3.223.41Xylp-(1→
1,5-Di-O-acetyl-2,3,4-tri-O-methyl-l-fucitol7.686.42Fucp-(1→
1,5-Di-O-acetyl-2,3,4,6-tetra-O-methyl-d-galacitol1.471.13Galp-(1→
1,3,5-Tri-O-acetyl-2,4-di-O-methyl-l-fucitol24.7337.92→3)-Fucp-(1→
1,4,5-Tri-O-acetyl-2,3-di-O-methyl-l-fucitol21.4228.23→4)-Fucp-(1→
1,2,5-Tetra-O-acetyl-3,4-di-O-methyl-fucitol5.247.54→2)-Fucp-(1→
1,3,4,5-Tetra-O-acetyl-2-O-methyl-fucitol24.4312.01→3,4)-Fucp-(1→
1,2,4,5-Tri-O-acetyl-3-O-methyl-l-fucitol8.36nd a→2,4)-Fucp-(1→
1,4,5-Tri-O-acetyl-2,3,6-tri-O-methyl-d-galactitol2.213.34→4)-Galp-(1→
1,4,5,6-Tetra-O-acetyl-2,3-di-O-methyl-d-galactitol1.24nd a→4,6)-Galp-(1→
a not detected.
Table
Table 3. 1H and 13C NMR spectral data of DAP4.
Table 3. 1H and 13C NMR spectral data of DAP4.
Residue bChemical Shifts (ppm) a
H1/C1H2/C2H3/C3H4/C4H5/C5H6/C6
A5.57/100.084.64/82.293.96/73.594.29/80.213.90/68.311.43/17.22
B5.50/95.234.21/76.154.60/75.764.71/82.123.90/68.311.43/17.22
C5.44/97.794.29/82.294.11/73.694.04/70.323.68/68.311.43/17.22
D5.41/110.163.85/73.42--/----/----/----/--
E5.34/99.204.29/73.594.11/77.943.96/74.713.90/68.311.30/17.22
F5.34/97.794.29/73.594.11/77.944.23/78.324.01/69.71.30/17.22
G5.16/99.204.29/73.404.03/73.594.34/79.954.01/69.71.30/17.22
H4.52/104.70--/----/----/----/--3.80/62.33
a Chemical shifts are referenced to internal acetone. b A–H correspond to →4)-α-l-Fucp(2SO4)-(1→, →3)-α-l-Fucp(4SO4)-(1→, →2)-α-l-Fucp-(1→, β-d-Xylp-(1→, →3)-α-l-Fucp-(1→, →3,4)-α-l-Fucp-(1→, →4)-α-l-Fucp-(1→ and β-d-Galp-(1→.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Qin, L.; Xu, H.; He, Y.; Liang, C.; Wang, K.; Cao, J.; Qu, C.; Miao, J. Purification, Chemical Characterization and Immunomodulatory Activity of a Sulfated Polysaccharide from Marine Brown Algae Durvillaea antarctica. Mar. Drugs 2022, 20, 223. https://doi.org/10.3390/md20040223

AMA Style

Qin L, Xu H, He Y, Liang C, Wang K, Cao J, Qu C, Miao J. Purification, Chemical Characterization and Immunomodulatory Activity of a Sulfated Polysaccharide from Marine Brown Algae Durvillaea antarctica. Marine Drugs. 2022; 20(4):223. https://doi.org/10.3390/md20040223

Chicago/Turabian Style

Qin, Ling, Hui Xu, Yingying He, Chen Liang, Kai Wang, Junhan Cao, Changfeng Qu, and Jinlai Miao. 2022. "Purification, Chemical Characterization and Immunomodulatory Activity of a Sulfated Polysaccharide from Marine Brown Algae Durvillaea antarctica" Marine Drugs 20, no. 4: 223. https://doi.org/10.3390/md20040223

APA Style

Qin, L., Xu, H., He, Y., Liang, C., Wang, K., Cao, J., Qu, C., & Miao, J. (2022). Purification, Chemical Characterization and Immunomodulatory Activity of a Sulfated Polysaccharide from Marine Brown Algae Durvillaea antarctica. Marine Drugs, 20(4), 223. https://doi.org/10.3390/md20040223

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop